ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest

ENDRA Life Sciences Inc. (NASDAQ:NDRA) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 40,600 shares, an increase of 43.5% from the February 28th total of 28,300 shares. Based on an average daily volume of 19,800 shares, the short-interest ratio is currently 2.1 days. Approximately 7.6% of the company’s shares are sold short.

ENDRA Life Sciences Price Performance

ENDRA Life Sciences stock remained flat at $4.05 during trading on Monday. The company had a trading volume of 5,246 shares, compared to its average volume of 99,379. The stock has a fifty day moving average price of $4.63 and a two-hundred day moving average price of $5.97. ENDRA Life Sciences has a 52-week low of $3.15 and a 52-week high of $875.00. The stock has a market capitalization of $2.17 million, a PE ratio of 0.00 and a beta of 0.43.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.